Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Northstar Gold Signs MOU with Hunan Nonferrous Ltd. to Develop Gold Resource (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s):  QNTM

Healthcare
FSD Pharma Inc. is a Canada-based biotechnology company. The Company operates through two segments: Biotechnology and Strategic Investments. Its Biotechnology segment is focused on furthering the research and development of the Company’s two primary drug candidates consisting of Lucid-MS and Lucid-PSYCH, as well as the development of UNBUZZD. The Company’s Strategic Investments segment is focused on generating returns and cashflow through the issuance of loans secured by residential or commercial real estate property. Lucid-PSYCH is a molecular compound identified for the potential treatment of mental health disorders. Lucid-MS is a molecular compound identified for the potential treatment of neurodegenerative disorders. UNBUZZD is a proprietary formulation of natural ingredients, vitamins, and minerals to help with liver and brain function for the purposes of potentially quickly relieving from the effects of alcohol consumption, such as inebriation, and restoring normal lifestyle.


CSE:QNTM - Post by User

Quantum BioPharma Ltd
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(137)
•••
Post by DavidRosenbergon Jun 22, 2023 10:48am
89 Views
Post# 35509101

Raza bokhari hasn’t paid fsd a cent yet wonder why

Raza bokhari hasn’t paid fsd a cent yet wonder why He lost arbitration 

  1. Dr. Bokhari and his counsel first appointed the Arbitrator who is a former Judge of the Ontario Superior Court of Justice with a lot of experience and all parties mutually agreed
  2. FSD Pharma has won multiple cases on which different judges presided. On top of that several cases have been dismissed which were brought against FSD Pharma by Dr. Bokhari and his associates. The cases were fought both in Canadian and US courts
  3. FSD Pharma has been awarded, not once but on multiple occasions. Dr. Bokhari has failed to pay anything so far. The total amount accruing with interest is running approximately 3 Million dollars 
  4. The link to the arbitration award can be found on the news page on FSD Pharma's website. The link is as follows: https://fsdpharma.com/wp-content/uploads/2023/05/2023-03-01-Application-Record-Applicant-FSD-Pharma-Inc.pdf

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities